These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 15613445)
41. CD70 as a therapeutic target in human malignancies. Grewal IS Expert Opin Ther Targets; 2008 Mar; 12(3):341-51. PubMed ID: 18269343 [TBL] [Abstract][Full Text] [Related]
42. Recombinant bispecific antibodies for cellular cancer immunotherapy. Müller D; Kontermann RE Curr Opin Mol Ther; 2007 Aug; 9(4):319-26. PubMed ID: 17694444 [TBL] [Abstract][Full Text] [Related]
43. Breast cancer vaccines: promise for the future or pipe dream? Mittendorf EA; Peoples GE; Singletary SE Cancer; 2007 Oct; 110(8):1677-86. PubMed ID: 17763371 [TBL] [Abstract][Full Text] [Related]
44. Immunotheranostics: breaking tolerance in immunotherapy using tumor autoantigens identified on protein microarrays. Chatterjee M; Draghici S; Tainsky MA Curr Opin Drug Discov Devel; 2006 May; 9(3):380-5. PubMed ID: 16729735 [TBL] [Abstract][Full Text] [Related]
45. A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2. Biburger M; Weth R; Wels WS J Mol Biol; 2005 Mar; 346(5):1299-311. PubMed ID: 15713482 [TBL] [Abstract][Full Text] [Related]
46. [Immunotherapy for cancer--modern immunologic strategies in oncology]. Halama N; Zoernig I; Jäger D Dtsch Med Wochenschr; 2008 Oct; 133(41):2105-8. PubMed ID: 18985564 [TBL] [Abstract][Full Text] [Related]
47. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer. Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284 [TBL] [Abstract][Full Text] [Related]
48. Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells. Chen YR; Juan HF; Huang HC; Huang HH; Lee YJ; Liao MY; Tseng CW; Lin LL; Chen JY; Wang MJ; Chen JH; Chen YJ J Proteome Res; 2006 Oct; 5(10):2727-42. PubMed ID: 17022644 [TBL] [Abstract][Full Text] [Related]
52. Tumor-associated antigen arrays to enhance antibody detection for cancer diagnosis. Zhang JY Cancer Detect Prev; 2004; 28(2):114-8. PubMed ID: 15068835 [TBL] [Abstract][Full Text] [Related]
53. [Target antigens for therapeutic antibodies in oncology: many candidates, few successes]. Ceze N; Probst A; Lecomte T; Ohresser M; Paintaud G; Watier H Bull Cancer; 2007; 94(7 Suppl):F129-36. PubMed ID: 17964990 [TBL] [Abstract][Full Text] [Related]
54. A simple test for detection of specific and unspecific immunological reactions in cancer. Ruíz Castañeda M Arch Invest Med (Mex); 1980; 11(1):83-93. PubMed ID: 7396635 [TBL] [Abstract][Full Text] [Related]
55. Determination of anti-malignin antibody and malignin in 1,026 cancer patients and controls: relation of antibody to survival. Bogoch S; Bogoch ES; Fager CA; Harris JH; Ambrus JL; Lux WE; Ransohoff JA J Med; 1982; 13(1-2):49-69. PubMed ID: 6750020 [No Abstract] [Full Text] [Related]
56. A strategy for investigating the CYP superfamily using targeted antibodies is a paradigm for functional genomic studies. Edwards RJ; Boobis AR; Davies DS Drug Metab Dispos; 2003 Dec; 31(12):1476-80. PubMed ID: 14625344 [TBL] [Abstract][Full Text] [Related]
57. Cancer immunology. Oettgen HF Trans Assoc Life Insur Med Dir Am; 1980; 64():118-21. PubMed ID: 7331170 [No Abstract] [Full Text] [Related]
58. Proteomic strategy for detection of circulating tumor cell surface antigens. Mints M; Souchelnytskyi S Exp Oncol; 2011 Sep; 33(3):193-5. PubMed ID: 21956479 [No Abstract] [Full Text] [Related]
59. [Destabilization of the plasma membrane as a mechanism of protecting neoplastic cells from the action of immunity]. Volkov EI; Chernavskii DS Usp Sovrem Biol; 1981; 91(3):419-32. PubMed ID: 7027660 [No Abstract] [Full Text] [Related]
60. Anti-nuclear autoantibodies of the aged reactive against the surface of tumor but not normal cells. Iakoubov L; Rokhlin O; Torchilin V Immunol Lett; 1995; 47(1-2):147-9. PubMed ID: 8537094 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]